Wilson Sonsini represented lead investors SR One and Norwest in the transaction.Rezo Therapeutics, a biotechnology company pioneering the integrated mapping of disease networks for precision therapeutics,…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
